In addition, increased genomic complexity, presumably owing to TP53 mutations, was observed in metastatic samples from 16 out of the 50 cancer types, with the gain of chromosome 12p, where KRAS is located, being particularly frequent in pancreatic cancer. This evidence concerns the gene KRAS and familial pancreatic carcinoma.